HOME Press Releases Veterinary Diagnostics Market worth 3.62 Billion USD by 2022



Veterinary Diagnostics Market worth 3.62 Billion USD by 2022


The report "Veterinary Diagnostics Market by Product (Instruments and Consumables), Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostics, Hematology, and Molecular Diagnostics), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, and Poultry), and End User - Global Forecast to 2022", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

     Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 368 market data tables and 36 figures spread through 294 pages and in-depth TOC on "Veterinary Diagnostics Market by Product (Instruments and Consumables), Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostics, Hematology, and Molecular Diagnostics), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, and Poultry), and End User - Global Forecast to 2022"
http://www.marketsandmarkets.com/Market-Reports/veterinary-diagnostics-market-26017452.html
Early buyers will receive 10% customization on reports.

The veterinary diagnostics market is expected to grow at a CAGR of 9.3% between 2017 and 2022 to reach 3.62 Billion by 2022. The growth in this market is attributed to factors such as growing animal population, rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, rising awareness about zoonotic diseases, and increasing number of veterinary practitioners across the globe.

The global veterinary diagnostics market is segmented based on product, technology, animal type, end user, and region. On the basis of product, this market is segmented into instruments and consumables. Based on technology, the global market is segmented into clinical biochemistry, urinalysis, immunodiagnostics, hematology, molecular diagnostics, and other veterinary diagnostics. In 2016, the immunodiagnostics segment accounted for the largest share of the global veterinary diagnostics market. It is also expected to register the highest growth during the forecast period. The highest growth of this segment is mainly attributed to the increasing adoption of lateral flow rapid tests and ELISA tests.

On the basis of animal type, the global veterinary diagnostics market is categorized into livestock and companion animals. The livestock segment accounted for the largest share of this market, while the companion animals segment is expected to register the highest growth during the forecast period. On the basis of end user, the market is segmented into reference laboratories, veterinary hospitals & clinics, point-of-care/in-house testing, and academic institutions & universities.

In 2016, North America accounted for the largest share of the veterinary diagnostics market. The largest share of this regional segment is attributed to increasing demand for animal-derived food products, rising animal healthcare expenditure, growing animal population, and rising awareness about zoonotic diseases. However, the market in the Asia-Pacific region is expected to register the highest CAGR, owing to growing animal population, increasing demand for animal-derived food products, rising awareness regarding animal health and welfare, and growing per capita animal health expenditure, especially in India and China.

IDEXX Laboratories, Inc. (U.S.), Abaxis, Inc. (U.S.), Neogen Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Heska Corporation (U.S.) together holds the major share of the veterinary diagnostics market and will continue to dominate the market between 2017 and 2022. Some of the other major players competing in this market are Zoetis, Inc. (U.S.), IDVet (France), Virbac (France), QIAGEN N.V. (Netherlands), URIT Medical Electronics Co., Ltd. (China), Mindray Medical International Limited (China), Eurolyser Diagnostica GmbH (Austria), Randox Laboratories Ltd. (U.K.), BPC Biosed srl (Italy), Jorgensen Laboratories, Inc. (U.S.), and PZ Cormay S.A. (Poland).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports